Guofei Li Selected Research

3- (2,4- diamino- 6- (3- hydroxyphenyl)pteridin- 7- yl)phenol

12/2019

Sorafenib-loaded hydroxyethyl starch-TG100-115 micelles for the treatment of liver cancer based on synergistic treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guofei Li Research Topics

Disease

8	Neoplasms (Cancer) 12/2023 - 05/2013
3	Liver Neoplasms (Liver Cancer) 12/2023 - 12/2019
3	Epilepsy (Aura) 01/2022 - 08/2017
1	Hypoxia (Hypoxemia) 12/2023
1	Neoplasm Metastasis (Metastasis) 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Seizures (Absence Seizure) 01/2022
1	Temporal Lobe Epilepsy 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Hypertriglyceridemia 01/2019
1	Hypercholesterolemia 01/2019
1	Hemolysis 10/2016

Drug/Important Bio-Agent (IBA)

3	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 12/2019
3	CamptothecinIBA 12/2020 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 11/2021
2	Capecitabine (Xeloda)FDA Link 01/2023 - 11/2021
2	regorafenibIBA 01/2023 - 04/2022
2	apatinibIBA 01/2023 - 04/2022
2	MicellesIBA 12/2020 - 12/2019
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2020 - 08/2017
2	LipidsIBA 01/2019 - 05/2013
2	Antineoplastic Agents (Antineoplastics)IBA 10/2016 - 01/2016
2	LactonesIBA 10/2016 - 01/2016
1	EnzymesIBA 12/2023
1	Nanoparticle Drug Delivery SystemIBA 12/2023
1	ChemokinesIBA 12/2023
1	Oxygen (Dioxygen)IBA 12/2023
1	Peptide Hydrolases (Proteases)FDA Link 12/2023
1	donafenibIBA 01/2023
1	lenvatinibIBA 01/2023
1	cabozantinibIBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2023
1	Morphine (MS Contin)FDA LinkGeneric 01/2023
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2023
1	AfatinibIBA 04/2022
1	icotinibIBA 04/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2022
1	VemurafenibIBA 04/2022
1	Gefitinib (Iressa)FDA Link 04/2022
1	Dasatinib (BMS 354825)FDA Link 04/2022
1	ceritinibIBA 04/2022
1	Imatinib Mesylate (Gleevec)FDA Link 04/2022
1	Lapatinib (GW572016)FDA Link 04/2022
1	CrizotinibIBA 04/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 11/2021
1	Cisplatin (Platino)FDA LinkGeneric 11/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	Fulvestrant (Faslodex)FDA Link 11/2021
1	acetonitrileIBA 11/2021
1	Ifosfamide FDA LinkGeneric 11/2021
1	IsotopesIBA 11/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2021
1	formic acid (formate)IBA 11/2021
1	Pemetrexed (MTA)FDA Link 11/2021
1	Tamoxifen FDA LinkGeneric 11/2021
1	Gemcitabine FDA Link 11/2021
1	Circular RNAIBA 01/2021
1	Lysine (L-Lysine)FDA Link 12/2020
1	Amino Acids FDA Link 12/2020
1	Amylases FDA Link 12/2020
1	3- (2,4- diamino- 6- (3- hydroxyphenyl)pteridin- 7- yl)phenolIBA 12/2019
1	Simvastatin (Zocor)FDA LinkGeneric 01/2019
1	ChloridesIBA 01/2019
1	BerberineIBA 01/2019
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2019
1	Drug CombinationsIBA 01/2019
1	ProdrugsIBA 10/2016

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2019
1	Therapeutics 12/2019
1	Microspheres (Microsphere) 05/2013